, Tracking Stock Market Picks
Enter Symbol:
Medicis Pharmaceutical Corporation (MRX) [hlAlert]

up 88.10 %

Medicis Pharmaceutical Corporation (MRX) upgraded to Overweight by Thomas Weisel

Posted on: Friday,  Oct 23, 2009  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight Medicis Pharmaceutical Corporation (NYSE: MRX) on 10/23/2009, when the stock price was $23.38. Since
then, Medicis Pharmaceutical Corporation has gained 88.11% as of 12/10/2012's recent price of $43.98.
If you would have followed this Thomas Weisel's recommendation on MRX, you would have gained 88.1% of your investment in 1144 days.

Medicis Pharmaceutical Corporation (Medicis) is an independent specialty pharmaceutical company focused primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the United States of products for the treatment of dermatological, aesthetic and podiatric conditions. It also markets products in Canada for the treatment of dermatological and aesthetic conditions. It offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis. It offers 18 branded products, including PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1%, and ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. On July 1, 2008, the Company acquired LipoSonix, Inc.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -6.85 %
1 Month up  6.61 %
3 Months up  7.57 %
1 YTD up  7.57 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/2/2009 8:25 AM Hold
15.97 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy